April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Agreement Among SD-OCT Instruments for Assessing Retinal Nerve Fiber Layer Thickness in the Diagnostic Innovations in Glaucoma Study (DIGS)
Author Affiliations & Notes
  • C. Bowd
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
  • M. Leite
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
    Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil
  • L. M. Zangwill
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
  • R. N. Weinreb
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
  • H. L. Rao
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
    L V Prasad Eye Institute, Hyderabad, India
  • A. Tafreshi
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
  • P. A. Sample
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
  • F. A. Medeiros
    Hamilton Glaucoma Center, Department of Ophthalmology, University of California San Diego, La Jolla, California
  • Footnotes
    Commercial Relationships  C. Bowd, Lace Elettronica, F; M. Leite, None; L.M. Zangwill, Carl Zeiss Meditec Inc., F; Heidelberg Engineering GmbH, F; Optovue Inc., F; Topcon Medical Systems Inc., F; R.N. Weinreb, Carl Zeiss Meditec Inc., F; Heidelberg Engineering GmbH, F; Optovue Inc., F; Topcon Medical Systems Inc., F; Alcon Laboratories Inc., C; Allergan Inc., C; Carl Zeiss Meditec Inc., C; Glaxo, C; Optovue Inc., C; Pfizer Inc., C; Topcon Medical Systems Inc., C; H.L. Rao, None; A. Tafreshi, None; P.A. Sample, Carl Zeiss Meditec Inc., F; Haag-Streit, F; Welch-Allyn, F; F.A. Medeiros, Alcon Laboratories Inc., F; Carl Zeiss Meditec Inc., F; Pfizer Inc., F; Alcon Laboratories Inc., C; Allergan Inc., C; Pfizer Inc., C; Alcon Laboratories Inc., R; Allergan Inc., R; Pfizer Inc., R; Reichert Inc., R.
  • Footnotes
    Support  NIH Grant EY11008, NIH Grant EY08208, Grants for participants' glaucoma medication (Alcon Laboratories Inc., Allergan Inc., Pfizer Inc., Merck Inc., Santen Inc.)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2973. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Bowd, M. Leite, L. M. Zangwill, R. N. Weinreb, H. L. Rao, A. Tafreshi, P. A. Sample, F. A. Medeiros; Agreement Among SD-OCT Instruments for Assessing Retinal Nerve Fiber Layer Thickness in the Diagnostic Innovations in Glaucoma Study (DIGS). Invest. Ophthalmol. Vis. Sci. 2010;51(13):2973.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To assess the agreement of peripapillary retinal nerve fiber layer thickness (RNFLT) measurements among three SD-OCT instruments. We also examined the influence on agreement of age, axial length and disease severity (standard perimetry mean deviation).

Methods: : 330 eyes (88 with glaucoma, 206 OHT or glaucoma suspect by disc appearance, 36 healthy) from 208 individuals were imaged using RTVue (v4.0.5.39), Spectralis (v3.1) and Cirrus (v4.5) in a single visit. Agreement among RNFLT measurements (globally and by quadrant) was assessed using Bland-Altman plots and associations between measurements were assessed using linear regression. The influence of covariates on agreement was assessed by regression analysis between each covariate and the differences in RNFLT measurements between pairs of instruments.

Results: : Bland-Altman analyses showed a significant fixed bias (measurements are consistently different) for almost all of the pair-wise agreements, and a significant proportional bias (measurements differ more as measured RNFLT increases) for most of the pair-wise agreements. In general, RTVue measurements were somewhat thicker than Spectralis and Cirrus measurements (by up to 15 µm). Linear regression indicated that pairwise measurements from each instrument were significantly positively correlated and these correlations were moderate to strong (R2 ranged from 0.30 for Spectralis and Cirrus nasal thickness to 0.87 for RTVue and Cirrus global thickness). Global RNFLT agreement between RTVue and Spectralis was affected by age (p = 0.002), agreement between Spectralis and Cirrus was affected by axial length (p = 0.004) and agreement between Spectralis and both RTVue and Cirrus was affected by disease severity (p ≤ 0.001).

Conclusions: : RNFL thickness measurements between several SD-OCT instruments are not entirely compatible and therefore these instruments likely cannot be used interchangeably. This may be due in part to difference in RNFL detection algorithms. Comparisons with histological measurements could determine which technique is most accurate.

Keywords: imaging/image analysis: clinical • nerve fiber layer 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×